FDA Inspection Shutdown Delays Drug Approvals

被引：0
|
作者：
Wechsler, Jill [1 ]
机构：
[1] BioPharm Int, Suzhou, Peoples R China
来源：
BIOPHARM INTERNATIONAL | 2021年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [41] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Lang Zheng
    Wenjing Wang
    Qiu Sun
    Signal Transduction and Targeted Therapy, 9
  • [42] FDA enforcement efforts and drug approvals trend upward
    Peters, Rita
    BIOPHARM INTERNATIONAL, 2018, 31 (03) : 6 - 6
  • [43] Value of 2016 FDA drug approvals: reversion to the mean?
    Schulze, Ulrik
    Ringel, Michael
    Panier, Valery
    Baedeker, Mathias
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 78 - 78
  • [44] FDA approvals
    不详
    AMERICAN FAMILY PHYSICIAN, 2003, 67 (12) : 2629 - 2629
  • [45] FDA approvals
    不详
    GERIATRICS, 2000, 55 (10) : 20 - 20
  • [46] FDA approvals
    不详
    AMERICAN FAMILY PHYSICIAN, 2002, 66 (10) : 2007 - 2007
  • [47] FDA drug approvals: No worse is simply not good enough
    不详
    NATURE BIOTECHNOLOGY, 1996, 14 (04) : 403 - 403
  • [48] Recent advances and FDA approvals in nanoformulations for drug delivery
    Asadi, Anahita
    Obidiro, Onyinyechi
    Elesho, Rashidat
    Agbaje, Kafilat
    Kochakzade, Mohammadali
    Karla, Pradeep Kumar
    JOURNAL OF NANOPARTICLE RESEARCH, 2025, 27 (01)
  • [49] ON FDA APPROVALS
    PICKNEY, ER
    DISCOVER, 1983, 4 (05): : 101 - 101
  • [50] FDA approvals
    不详
    GERIATRICS, 2000, 55 (01) : 24 - 24
12345